Unknown

Dataset Information

Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.


ABSTRACT:

Objective

Identifying simple biomarkers that can predict or track disease progression in patients with spinal muscular atrophy (SMA) remains an unmet clinical need. To test the hypothesis that serum creatinine (Crn) could be a prognostic biomarker for monitoring progression of denervation in patients with SMA, we determined whether serum Crn concentration correlates with disease severity in patients with SMA.

Methods

We examined a cohort of 238 patients with SMA with 1,130 Crn observations between 2000 and 2016. Analyses were corrected for age, and 156 patients with SMA had dual-energy x-ray absorptiometry data available for correction for lean mass. We investigated the relationship between Crn and SMA type, survival motor neuron 2 (SMN2) copies, and Hammersmith Funct

SUBMITTER: Alves CRR 

PROVIDER: S-EPMC7238944 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature